Literature DB >> 13271569

The enhancement of peripheral glucose utilization by glucagon.

H ELRICK, C J HLAD, T WITTEN.   

Abstract

Entities:  

Keywords:  BLOOD SUGAR/effect of drugs on; PANCREAS/hormones

Mesh：

Substances：

Year:  1955        PMID： 13271569      PMCID： PMC438767          DOI： 10.1172/JCI103239

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  10 in total

1.  Purification and crystallization of glucagon.

Authors:  A STAUB; L SINN; O K BEHRENS
Journal:  J Biol Chem       Date:  1955-06       Impact factor: 5.157

2.  The blood flow in skin and muscle of the human forearm.

Authors:  K E COOPER; O G EDHOLM; R F MOTTRAM
Journal:  J Physiol       Date:  1955-05-27       Impact factor: 5.182

3.  Effect of glucagon on peripheral utilization of glucose in man.

Authors:  T B VAN ITALLIE; M C MORGAN; L B DOTTI
Journal:  J Clin Endocrinol Metab       Date:  1955-01       Impact factor: 5.958

4.  Glucagon, the hyperglycemic glycogenolytic hormone of the pancreas.

Authors:  P P FOA
Journal:  Adv Intern Med       Date:  1954

5.  Influence of the liver on uptake of glucose by extrahepatic tissues.

Authors:  G LANG; M S GOLDSTEIN; R LEVINE
Journal:  Am J Physiol       Date:  1954-06

6.  The effect of the hyperglycemic factor on the metabolism of glucose by the extrahepatic tissues.

Authors:  D R DRURY; A N WICK; J W SHERRILL
Journal:  Diabetes       Date:  1954 Mar-Apr       Impact factor: 9.461

7.  Glucagon, the hyperglycemic agent in pancreatic extracts; a possible factor in certain types of diabetes.

Authors:  I J PINCUS; J Z RUTMAN
Journal:  AMA Arch Intern Med       Date:  1953-11

8.  Endocrine regulation of the blood sugar.

Authors:  J W CONN
Journal:  Ann Intern Med       Date:  1953-02       Impact factor: 25.391

9.  Effect of hyperglycemic-glycogenolytic factor and epinephrine on liver phosphorylase.

Authors:  E W SUTHERLAND; C F CORI
Journal:  J Biol Chem       Date:  1951-02       Impact factor: 5.157

10.  Purification and crystallization of hyperglycemic glycogenolytic factor (HGF).

Authors:  A STAUB; L SINN; O K BEHRENS
Journal:  Science       Date:  1953-06-05       Impact factor: 47.728
  10 in total
  16 in total

1.  THE EFFECT OF GLUCAGON ON NET SPANCHNIC BALANCES OF GLUCOSE, AMINO ACID NITROGEN, UREA, KETONES, ANS OXYGEN IN MAN.

Authors:  R F KIBLER; W J TAYLOR; J D MYERS
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  The use of glucagon in insulin coma therapy.

Authors:  B BLACKMAN
Journal:  Psychiatr Q       Date:  1961-07

3.  [On the effect of insulin and glucagon on glucose metabolism of the epididymal fat appendix of rats in vitro. II. The effect of glucagon in comparison with the effect of insulin].

Authors:  H WOERNER; K F WEINGES
Journal:  Klin Wochenschr       Date:  1961-03-01

4.  [On the determination of blood insulin at the epididymal fat appendix of the rat by means of labelled glucose. V. The effect of human and bovine growth hormones and other metabolic hormones on the carbohydrate metabolism of isolated rat fatty tissue].

Authors:  H DITSCHUNEIT; R ZIEGLER; E F PFEIFFER
Journal:  Klin Wochenschr       Date:  1961-04-15

5.  The effect of glucagon on carbohydrate metabolism in normal human beings.

Authors:  P K BONDY; L R CARDILLO
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

6.  The significance of glucagon.

Authors:  G A WRENSHALL
Journal:  Can Med Assoc J       Date:  1956-06-01       Impact factor: 8.262

7.  Effect of carbohydrate ingestion on postprandial lipemia.

Authors:  M J ALBRINK; E B MAN
Journal:  Am J Dig Dis       Date:  1957-11

8.  The physiologic significance of the secretion of endogenous insulin into the portal circulation. I. Comparison of the effects of glucagon-free insulin adminstered via the portal vein and via a peripheral vein on the magnitude of hypoglycemia and peripheral glucose utilization.

Authors:  L L MADISON; R H UNGER
Journal:  J Clin Invest       Date:  1958-05       Impact factor: 14.808

9.  The clinical and metabolic effects of glucagon.

Authors:  C EZRIN; J M SALTER; M A OGRYZLO; C H BEST
Journal:  Can Med Assoc J       Date:  1958-01-15       Impact factor: 8.262

10.  Carbohydrate metabolism in intact skeletal muscle in man during the night.

Authors:  R ANDRES; K L ZIERLER
Journal:  J Clin Invest       Date:  1956-09       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.